Seeking Alpha

Edwards Lifesciences (EW) +6.5% following news that an FDA advisory panel voted almost...

Edwards Lifesciences (EW) +6.5% following news that an FDA advisory panel voted almost unanimously to recommend the expanded use of the company's Sapien artificial heart valve as an alternative to open heart surgery. The panel did have caveats, though, including an increased risk of stroke. The FDA may make a decision in October.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)